BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31290564)

  • 1. Infliximab reduces activated myeloid dendritic cells, different macrophage subsets and CXCR3-positive cells in granuloma annulare.
    Bürgler C; Vinay K; Häfliger S; Klötgen HW; Yawalkar N
    J Dermatol; 2019 Sep; 46(9):808-811. PubMed ID: 31290564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granuloma annulare: a case treated with infliximab successfully.
    Giunta A; Chiricozzi A; Cannizzaro MV; Dattola A; Ruzzetti M; Nisticò SP; Chimenti S
    G Ital Dermatol Venereol; 2017 Apr; 152(2):193-195. PubMed ID: 28166622
    [No Abstract]   [Full Text] [Related]  

  • 3. Dimethyl Fumarate Used as an Effective Treatment for Granuloma Annulare Disseminatum: An Immunohistochemical Case Study.
    Gabutti M; Heidemeyer K; Seyed Jafari SM; Bossart S; Hunger RE; Feldmeyer L; Yawalkar N
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid improvement of recalcitrant disseminated granuloma annulare upon treatment with the tumour necrosis factor-alpha inhibitor, infliximab.
    Hertl MS; Haendle I; Schuler G; Hertl M
    Br J Dermatol; 2005 Mar; 152(3):552-5. PubMed ID: 15787827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of biologics in the treatment of chronic granuloma annulare.
    Chen A; Truong AK; Worswick S
    Int J Dermatol; 2019 May; 58(5):622-626. PubMed ID: 30618205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of granuloma annulare and suppression of proinflammatory cytokine activity with tofacitinib.
    Wang A; Rahman NT; McGeary MK; Murphy M; McHenry A; Peterson D; Bosenberg M; Flavell RA; King B; Damsky W
    J Allergy Clin Immunol; 2021 May; 147(5):1795-1809. PubMed ID: 33317858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-tumor necrosis factor-α treatment with infliximab for disseminated granuloma annulare.
    Murdaca G; Colombo BM; Barabino G; Caiti M; Cagnati P; Puppo F
    Am J Clin Dermatol; 2010 Dec; 11(6):437-9. PubMed ID: 20515080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infliximab induces downregulation of the IL-12/IL-23 axis in 6-sulfo-LacNac (slan)+ dendritic cells and macrophages.
    Brunner PM; Koszik F; Reininger B; Kalb ML; Bauer W; Stingl G
    J Allergy Clin Immunol; 2013 Nov; 132(5):1184-1193.e8. PubMed ID: 23890755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infliximab in recalcitrant granuloma annulare.
    Amy de la Breteque M; Saussine A; Rybojad M; Kramkimel N; Vignon Pennamen MD; Bagot M; Guibal F
    Int J Dermatol; 2016 Feb; 55(2):220-2. PubMed ID: 24962456
    [No Abstract]   [Full Text] [Related]  

  • 10. Histological and immunohistochemical study of granuloma annulare and subcutaneous granuloma annulare in children.
    Stefanaki K; Tsivitanidou-Kakourou T; Stefanaki C; Valari M; Argyrakos T; Konstantinidou CV; Karentzou O; Katsambas A
    J Cutan Pathol; 2007 May; 34(5):392-6. PubMed ID: 17448194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of disseminated granuloma annulare with adalimumab.
    Rosmarin D; LaRaia A; Schlauder S; Gottlieb AB
    J Drugs Dermatol; 2009 Feb; 8(2):169-71. PubMed ID: 19213233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of recalcitrant granuloma annulare (GA) with adalimumab: A single-center, observational study.
    Min MS; Lebwohl M
    J Am Acad Dermatol; 2016 Jan; 74(1):127-33. PubMed ID: 26552891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Janus kinase inhibition induces disease remission in cutaneous sarcoidosis and granuloma annulare.
    Damsky W; Thakral D; McGeary MK; Leventhal J; Galan A; King B
    J Am Acad Dermatol; 2020 Mar; 82(3):612-621. PubMed ID: 31185230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colocalization of C4d deposits/CD68+ macrophages in rheumatoid nodule and granuloma annulare: immunohistochemical evidence of a complement-mediated mechanism in fibrinoid necrosis.
    Knoess M; Krukemeyer MG; Kriegsmann J; Thabe H; Otto M; Krenn V
    Pathol Res Pract; 2008; 204(6):373-8. PubMed ID: 18339486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disseminated granuloma annulare--treatment with fumaric acid esters.
    Eberlein-König B; Mempel M; Stahlecker J; Forer I; Ring J; Abeck D
    Dermatology; 2005; 210(3):223-6. PubMed ID: 15785051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granuloma Annulare.
    Keimig EL
    Dermatol Clin; 2015 Jul; 33(3):315-29. PubMed ID: 26143416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of factor XIII-A is a valuable tool for distinguishing dendritic cells and tissue macrophages in granuloma annulare and necrobiosis lipoidica.
    Töröcsik D; Bárdos H; Hatalyák Z; Dezső B; Losonczy G; Paragh L; Péter Z; Balázs M; Remenyik E; Adány R
    J Eur Acad Dermatol Venereol; 2014 Aug; 28(8):1087-96. PubMed ID: 24237365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of disseminated granuloma annulare with low-dose fumaric acid.
    Weber HO; Borelli C; Röcken M; Schaller M
    Acta Derm Venereol; 2009; 89(3):295-8. PubMed ID: 19479130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function.
    Bedini C; Nasorri F; Girolomoni G; Pità Od; Cavani A
    Br J Dermatol; 2007 Aug; 157(2):249-58. PubMed ID: 17489975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granuloma annulare and human immunodeficiency virus infection.
    Toro JR; Chu P; Yen TS; LeBoit PE
    Arch Dermatol; 1999 Nov; 135(11):1341-6. PubMed ID: 10566832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.